MétaCan
Menu
Back to cohort
Record W4410488748 · doi:10.1016/j.bneo.2025.100117

Outcomes and factors influencing survival in patients with diffuse large B-cell lymphoma: a population-based analysis

2025· article· en· W4410488748 on OpenAlexafffundabout
Inna Y. Gong, Michael Crump, Anca Prica, Andrew Calzavara, Ning Liu, Tiana Kordbacheh, Danielle Rodin, David Hodgson, Lee Mozessohn, Matthew C. Cheung, John Kuruvilla

Bibliographic record

VenueBlood Neoplasia · 2025
Typearticle
Languageen
FieldMedicine
TopicLymphoma Diagnosis and Treatment
Canadian institutionsSunnybrook Health Science CentrePrincess Margaret Cancer CentreUniversity of Toronto
FundersInstitut canadien d'information sur la santéPrincess Margaret Cancer FoundationMinistry of Long-Term CareInstitute for Clinical Evaluative SciencesMinistry of Health, UgandaOntario Ministry of Health and Long-Term Care
KeywordsDiffuse large B-cell lymphomaLymphomaPopulationSurvival analysisMedicineOncologyInternal medicineEnvironmental health

Abstract

fetched live from OpenAlex

ABSTRACT Given the rapidly evolving treatment landscape for diffuse large B cell lymphoma (DLBCL), we performed a contemporary analysis of survival outcomes in patients aged ≥18 years with DLBCL at the population level using linked administrative datasets in Ontario, Canada (ICES). Among 8,675 patients (median age 67, 44% female) treated with frontline rituximab-based therapy, 1,675 (19%) were treated with second-line therapy (2L). The 2-year and 5-year overall survival (OS) from 2L were 33% and 26%, respectively. Univariate analysis demonstrated that curative-intent therapy (autologous stem cell transplant [ASCT]) (58% of patients) was associated with better OS compared to palliative radiotherapy (hazard ratio [HR] 0.56, p<0.0001). Patients ≥60 years showed inferior OS compared to those <60 (age 60-69: HR 1.35, p=0.0002; age 70-79: HR 1.64, p<0.0001; age ≥80: HR 2.08, p<0.0001). Additionally, early relapse was associated with worse outcomes compared to relapses occurring after 2 years (<3 months: HR 1.45, p=0.0002; 3-6 months: HR 1.51, p=0.0001; 6-12 months: HR 1.88, p<0.0001). Multivariable analysis confirmed these associations, while accounting for LDH, comorbidity burden, frailty, and income. Exploratory analysis indicated that third-line chimeric antigen receptor T cell therapy (CAR-T) was associated with improved outcomes compared to a historical cohort of patients treated with palliative therapy prior to 2020 (2-year OS 56% vs. 21%). This population-based analysis suggests that curative intent therapy (ASCT and CAR-T) is associated with improved OS over conventional treatment approaches. The outcomes presented here provide benchmarks for future analyses aimed at assessing the effects of novel treatments in the 2L on outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.046
Threshold uncertainty score0.581

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.004
GPT teacher head0.222
Teacher spread0.218 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes3
Has abstractyes

Explore more

Same venueBlood NeoplasiaSame topicLymphoma Diagnosis and TreatmentFrench-language works237,207